The Exact Email Campaign to Reach C-Suite at New England Biotech SaaS Companies (2026)

The Exact Email Campaign to Reach C-Suite at New England Biotech SaaS Companies (2026)

Quick Answer: After you’ve built a list of C-suite leads at New England biotech SaaS companies using Origami, you can immediately launch a multi-touch email sequence without leaving the platform. Origami’s built-in email sequencer — included on all paid plans — turns that list into a campaign with automated follow-ups, tracking, and smart un-enrollment. No CSV exports, no separate tooling.

If you’ve followed the companion guide on how to build a list of C-Suite Leads at New England Biotech SaaS Companies, you already have a targeted list of CEOs, CTOs, CFOs, and other senior leaders inside your browser. Now we turn that list into opened emails and booked meetings. This post walks through how to refine the list for maximum impact, the exact 3-touch email sequence you can steal, and how to send it all from Origami’s sequencer — with real data on what to expect.

Step 1: Refine and Segment Your List

Even the best list contains people who shouldn’t all get the same message. In Origami, your enriched contacts already come with titles, company size estimates, industry tags, and sometimes funding stage — so you can split the list without any manual research.

Segmentation Dimensions That Matter for Biotech SaaS

• Role: CEO vs. CTO vs. CFO vs. VP of Product. A CTO cares about architecture and compliance (FDA, GxP, HIPAA); a CEO cares about revenue growth and time-to-market; a CFO wants to see unit economics. Create separate sequences for each group.
• Company size: Distinguish pre-seed/seed (<20 employees) from growth-stage (50–200) from enterprise (200+). The pain point changes from “how do we build a scalable data pipeline” to “how do we pass an FDA audit without hiring 10 more QA engineers.”
• Location: New England isn’t just Boston. Cambridge/Waltham startups are different from mid-size firms in the Merrimack Valley or Connecticut. If you’ve targeted a specific sub-region, even a “Boston area” mention in the email can lift replies.
• Technical stack signals: Origami often enriches a company’s tools used — AWS, Veeva, Benchling, Snowflake, etc. If you integrate with (or complement) any of those, you can tailor the message instantly.

Qualifying a “Ready” Lead

A qualified lead isn’t just a name and email. Look for signs that the company is actively investing in digital transformation: recent funding, job listings for data engineers or regulatory specialists, leadership changes. Origami’s AI pulls live web signals, so you can scan for these markers inside the contact record.

Remove anyone who doesn’t meet your core ICP. For example, if you only work with post-Series A companies, filter out all pre-revenue labs. The smaller and sharper the list, the better the response rate — and the less you waste credits.

Segment Naming

Inside Origami, save each segment as a separate list (e.g., “Biotech SaaS CEOs – Boston – 50+ employees”). You’ll attach each segment to a slightly different version of the sequence later, or you can ask the AI to generate a variant for each segment automatically.

Step 2: Create the 3-Touch Email Sequence

Origami gives you two ways to build your sequence.

1. Paste your own templates: Write the messages yourself, set the delays between touches (Day 1, Day 3, Day 7 — or whatever cadence you want), and hit launch.
2. Let the agent write it: Ask Origami’s AI agent to generate a personalized 3-day email sequence for all your leads automatically. The agent writes the messages based on each lead’s profile data — title, company, industry — so every message feels custom.

Below is a full example 3-touch sequence written specifically for C-suite executives at biotech SaaS companies in New England. You can copy these messages verbatim, tweak the placeholders, and paste them into Origami. Each message is 50–100 words, written in the direct, zero-fluff tone that actually gets read by busy execs.

Day 1: Initial Cold Email

Subject: Idea for scaling [Company]’s data pipeline
Preview text: Compliance doesn’t have to slow you down.

Hi [First Name],

I’ve been following [Company]’s work in [specific area, e.g., genomic analysis] — impressive traction. Many biotech SaaS leaders here in Boston tell me that as they scale, maintaining GxP-compliant data flows becomes a bottleneck.

We built [Your Solution] to automate validation steps and integrate with your existing LIMS/ELN. Could I share a 5-minute case study? It’s a lightweight overview. Worth a look?

—[Your Name]

Why it works: It’s specific to biotech SaaS (GxP, LIMS/ELN), references the New England location, and asks for a micro-commitment — not a meeting.

Day 3: Follow-Up (Different Angle)

Subject: Re: scaling + one more thought
Preview text: Something else you might find relevant

Hi [First Name],

Following up on my note. Last week, a CTO at a Boston biotech SaaS mentioned they reduced QA review time by 40% after implementing our automated audit trails.

If you’re dealing with FDA audit prep or scaling your engineering team, it might be worth a quick chat. No pitch, just a friendly discussion on what’s working in the region.

—[Your Name]

Why it works: It introduces social proof (peer in similar role/region), reframes the value around a specific metric, and keeps the ask low-pressure.

Day 7: Final Breakup Email

Subject: One last thing on [Company]’s compliance pipeline
Preview text: If it’s not a priority, no worries.

Hi [First Name],

I know you’re busy — this is my final email. I genuinely believe [Your Solution] could help [Company] reduce manual compliance overhead as you scale.

If you’re not the right person, could you point me to the right contact? If timing is off, I’ll circle back in Q3. Either way, keep up the great work in [niche].

—[Your Name]

Why it works: The breakup email triggers a final response — either a referral or a soft “not now” that keeps the door open. No passive-aggressive tone.

Customizing for Different Roles

• CEO: Replace “data pipeline” with “time-to-revenue” and mention competitive differentiation.
• CTO: Stick with technical specifics (HIPAA compliance, lab system integration, validation).
• CFO: Focus on cost — “manual QA processes that eat 30% of engineering budget.”

You can create three versions of each touch and attach them to different segments within the same Origami campaign. Or, if you’re using the AI-generated template option, describe the segment in plain English and Origami’s agent will adapt the language automatically.

Step 3: Send the Sequence Directly from Origami

Once your messages are ready, you don’t export anything. Inside Origami’s sequencer, you:

1. Select the segment (e.g., “Biotech SaaS CEOs – Boston – 50+”).
2. Choose your templates (or let the AI generate them per lead).
3. Set the delays: Day 1, Day 3, Day 7 (or your preferred cadence).
4. Click Launch Campaign.

Origami sends each touch automatically, respecting the delay schedule. There’s no SMTP setup — the platform handles sending on your behalf.

Tracking and Insights

In the same dashboard where you built the list, you’ll see:

• Opens and clicks per touch, per contact.
• Replies logged in-line; you can reply back directly from the thread.
• Prospect context stays visible: while viewing a contact’s activity, you can still see their enriched profile (title, company, tools used), so you know why you reached out in the first place.

Smart Un-enrollment

If a prospect replies — even a “not interested” — Origami automatically removes them from the sequence. You won’t accidentally send a breakup email to someone who already booked a meeting. This alone saves countless embarrassing moments.

What Does the Sequencer Cost?

The built-in email sequencer is included on all Origami paid plans. You pay only for the credits you consume to enrich leads (and you get 1,000 free credits on sign-up, no credit card required). Sending the emails themselves doesn’t cost extra — it’s part of the platform. Plans start at $29/month.

What Response Rate to Expect

With a well-refined list of 200–300 biotech SaaS C-suite contacts and the messaging above, I typically see a 4–7% reply rate on the first touch, with an additional 2–4% on follow-ups. The final breakup email generates another 1–2% — often the warmest leads because they realize you’re persistent but respectful.

Those numbers hold up when:

• The list is hyper-local (New England, not a national blast).
• The industry language is precise (no “we help healthcare companies digitize”).
• The ask is small (case study, quick chat, or referral).

If you’re seeing sub-3% replies, it’s usually a list-quality problem — too broad, wrong titles, or stale contacts. Origami’s AI enriches from live web data, so bounce rates should be near zero. If they aren’t, revisit your prompt or review the list manually.

When to Iterate on Messaging vs. the List

• Low opens on Touch 1: Your subject line isn’t triggering curiosity. Test more specific subjects like “Boston biotech scaling” vs. “Quick question.”
• High opens, low replies: The body copy isn’t compelling enough. Try a different angle — maybe shift from “compliance” to “speed to market” or “reducing audit costs.”
• Replies but no meetings: Your call to action is too big. Instead of “let’s schedule a call,” ask “would you be open to a 10-minute conversation next week?”
• High bounce or wrong contact: Go back to the list and refine the targeting prompt in Origami. The AI can re-run the search with tighter filters.

Since you can create and launch sequences in minutes, you can test a new subject line or a different segment same afternoon. No waiting on ops teams.